SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-11-347533
Filing Date
2011-12-21
Accepted
2011-12-20 18:05:55
Documents
3
Period of Report
2011-12-20
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT NO. 2 d267757d8ka.htm 8-K/A 20237
2 AUDITED FINANCIAL STATEMENTS d267757dex991.htm EX-99.1 419065
3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS d267757dex992.htm EX-99.2 195422
  Complete submission text file 0001193125-11-347533.txt   635906
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-23155 | Film No.: 111272995
SIC: 2836 Biological Products, (No Diagnostic Substances)